Jiangsu Recbio Technology (HKG:2179) said the Hong Kong Stock Exchange has granted listing approval for its Hong Kong share full circulation application, according to a Feb. 6 bourse filing.

The approval covers the conversion of about 142 million unlisted shares into Hong Kong-listed shares.

The converted shares represent about 22.67% of the company's total issued share capital.

Upon completion of the conversion, Jiangsu Recbio's H-shares will increase to about 458.1 million, accounting for roughly 73.17% of total issued shares.